- From: Richard Boyce <rdb20@pitt.edu>
- Date: Sat, 30 Apr 2016 07:45:50 -0400
- To: <public-semweb-lifesci@w3.org>, <malone@Pharmacy.arizona.edu>, <draper.evan@mayo.edu>, <gmcevoy@ashp.org>, <jeffnielson@gmail.com>, <jrhorn@u.washington.edu>, <jp@rxdoc.me>, <jmbanda@stanford.edu>, <lori.idemoto@gmail.com>, <michel.dumontier@stanford.edu>, <michael.liebman@ipqanalytics.com>, <mail@jackpo.org>, <nancy@worldvista.org>, <hassanzadeh@us.ibm.com>, <Sam.habiel@gmail.com>, <scott.nelson.rx@gmail.com>, <serkanayvaz@gmail.com>, <valerie@genelex.com>
- Message-ID: <57249AEE.7040706@pitt.edu>
Dear Colleagues, Below are pasted the minutes of the Content sub-group for the PDDI DDI Minimum Information Model Task Force [1]. Minutes for 4/29/2016 (Content subgroup) In Attendance : Evan Draper, Lori Idemoto, Brian LeBaron, Sam Habiel, Richard Boyce, Michael Liebman, Dan Malone, Scott Nelson, John Poikonen, Scott Nelson Meeting recording: http://goo.gl/lbmkDI(some missing audio for the first 2 minutes) Meeting: * Update from the Standard subteam o Toward writing an Interest Group Note + Rich re-organized the initial draft note to focus on introduction and background with stakeholder descriptions, use cases, and user scenarios # An github project and initial draft: * GitHub project: https://github.com/W3C-HCLS/w3c-ddi * Example draft : http://goo.gl/7ZaE94 + Rich created google docs that we will write in and then the editors will migrate the content into the W3C note format # These are linked to from the http://goo.gl/7ZaE94 and also listed here: * Introduction and motivation for the W3C DDI Minimum Information Model IG Note <https://goo.gl/YWRMV3> * Stakeholder Descriptions <https://docs.google.com/document/d/1AbWuONYTrFOV95OhjlRwrm3ZJy5jjvzJ-dywO5OZyFY/edit#> * DDI Minimum Information Model User Scenarios <https://docs.google.com/document/d/1HE8r8nmJBHRrtbE6YrNfK00Ztkev44-dNk-Rm6MP92U/edit> * Knowledge Representation Core Considerations <https://docs.google.com/document/d/14saXL4qhusPHxxN1Aymc5z_u7vH3j3V-YF9TKNjRxLQ/edit> o Progress on definitions + Discussion of stakeholders # Rich has pulled this into two google docs in the format of user profile and scenarios for discussion by the sub-team with the goal of finalizing by the next call * Stakeholder Descriptions <https://docs.google.com/document/d/1AbWuONYTrFOV95OhjlRwrm3ZJy5jjvzJ-dywO5OZyFY/edit#>and DDI Minimum Information Model User Scenarios <https://docs.google.com/document/d/1HE8r8nmJBHRrtbE6YrNfK00Ztkev44-dNk-Rm6MP92U/edit> o He will send a request to complete a qualtrics survey eliciting feedback on each user scenario + We agreed as a team to use the following process for moving the current suggested definitions <https://docs.google.com/spreadsheets/d/1dhUp496riwZ0AHqRP7I85oEvuP2jjEI0rcw1Fcm2zI8/edit#gid=0>to final definitions as follows: # For a given information category (e.g., clinical consequences) Rich will summarize the currently suggested candidate definitions * Including any references to the terminologies or publications where they came from * He will also show examples of the definitions from the contextualizing decision trees created for the included interactions <https://docs.google.com/spreadsheets/d/1DIeIuo7tZ6nVvd6MdO2xzzLtOSPXjAHI-DdBe9M3kiw/edit> # Rich will create a qualtrics survey for each summary to elicit agreement on a final proposed definition * This process likely be iterative * PDDIs to focus on o The content workgroup agreed upon 10 PDDIs to include: https://goo.gl/rYpmjt + These cover the following information aspects: # can (and should) be contextualized for specific patients or clinical circumstances, # applies at the class level, does not apply at the class level, # the mechanism is known and is pharmacokinetic, the mechanism is known and is pharmacodynamic + More forthcoming... o Decision trees useful for contextualizing the PDDIs, provide management options, and linking to relevant evidence will be created for all of them + Done already for 2 of the 10 now included # It was agreed that Rich could share the completed decision trees with standard development team members as PDF documents with clear attribution and a “do not share” watermark * Next steps o All will complete doodles to schedule new meetings for the next few months o Rich will create a qualtrics survey for each summary to elicit feedback/suggestions on two PDDIs for which the mechanism is not known + Other surveys will likely follow to finalize the PDDIs for the remaining categories o Work will begin on decision trees for the accepted pairs - review can occur at each of the next meetings -- Richard D Boyce, PhD Assistant Professor of Biomedical Informatics Faculty, Center for Pharmaceutical Policy and Prescribing Faculty, Geriatric Pharmaceutical Outcomes and Gero-Informatics Research and Training Program University of Pittsburgh rdb20@pitt.edu Office: 412-648-9219 Twitter: @bhaapgh
Received on Saturday, 30 April 2016 11:46:22 UTC